Loading ....
Contact us to order
Tel
+1 866.986.9598
Wuhan HealthCare Biotechnology Co., Ltd.
view supplier detailsCredit card payments now incur a 3% fee.
Wuhan HealthCare Biotechnology Co., Ltd.
view supplier detailsCredit card payments now incur a 3% fee.
| Mfr.No. | KL-CML01 | ||
| Gene Name | BCR/ABL | ||
| Fluorophore | Orange-Red/Green | ||
| Chromosome | 9, 22 | ||
| Description |  The ABL probe was labeled with orange red dye and the green dye was used to mark the BCR probe. In situ hybridization technique could be used to combine the two probes into the target detection site. |
||
| Description | Lymphatic hematopoietic system tumor | ||
| Clinical Significance | BCR/ABL fusion gene is a common cytogenetic anomaly in patients with chronic myelocytic leukemia (CML). The BCR/ABL fusion gene can be found in 90% of the CML patients. The prognosis of patients with BCR/ABL fusion gene is poor. It is clinically possible to use the BCR/ABL fusion gene to selectively use the molecular targeted therapeutic drugs . In addition, clinicians can combine other signs of patients to identify patients more effectively. | ||
| Disease | Chronic Myeloid Leukemia (CML) | ||
| Location | 9q34.11-13/22q11.22-23 | ||
| Size Specifications |  |
||
| Image(s) |
|
